Reyataz Sales Data

Rank 75 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Reyataz U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 75 (2) -1.38% -2.53%
Q3 2013 73 (8) -7.09% -9.20%
Q2 2013 65 (1) -0.17% -0.38%
Q1 2013 64 (2) 0.18% -5.42%
Q4 2012 62 (1) 0.65% 0.36%
Q3 2012 63 (2) 1.20% -1.08%
Q2 2012 65 (6) -2.02% -1.76%
Q1 2012 71 (1) 1.45% -1.73%
Q4 2011 72 (2) 3.45% 3.21%
Q3 2011 70 (1) -2.22% -1.75%
Q2 2011 71 (5) 1.96% 1.79%
Q1 2011 76

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web3)